PT-141, also known as Bremelanotide, is a peptide developed to address sexual dysfunction in both men and women. Unlike other treatments, PT-141 works directly on the central nervous system, activating melanocortin receptors to enhance sexual arousal and desire.
It is particularly effective for treating erectile dysfunction in men and hypoactive sexual desire disorder (HSDD) in women. Unlike medications targeting vascular function, PT-141 acts neurologically, offering a unique solution for individuals unresponsive to traditional treatments.
In addition to its sexual health benefits, PT-141 may boost mood and energy levels, contributing to overall well-being. Administered via subcutaneous injection, it has a rapid onset and lasting effects. Always consult a healthcare professional to ensure safe and effective use.
